Skip to content

What not to mix with fusidic acid?

4 min read

Co-administration of systemic fusidic acid and statins is associated with a high fatality rate, with some studies showing mortality in over 20% of reported rhabdomyolysis cases [1.4.1]. So, what not to mix with fusidic acid is a critical question for patient safety.

Quick Summary

Systemic fusidic acid should not be mixed with statins due to a high risk of fatal rhabdomyolysis. Caution is also required with anticoagulants and certain antivirals.

Key Points

  • Statins are Contraindicated: Mixing systemic fusidic acid with statins (e.g., atorvastatin, simvastatin) is strictly contraindicated due to a high risk of fatal rhabdomyolysis [1.2.5].

  • Rhabdomyolysis Risk: This interaction can cause severe muscle breakdown, leading to kidney failure and death [1.4.1].

  • Anticoagulant Caution: Use with oral anticoagulants like warfarin can increase bleeding risk, requiring close monitoring and dose adjustments [1.5.1, 1.2.6].

  • HIV Drug Interaction: Combining with HIV protease inhibitors (e.g., ritonavir, saquinavir) can raise drug levels and lead to liver toxicity [1.2.6].

  • Topical vs. Systemic: The risk of serious interactions is linked to systemic (oral/IV) fusidic acid; topical forms (creams/ointments) have minimal systemic absorption and are considered safe from these interactions [1.4.3, 1.8.2].

  • Enzyme Inhibition: Fusidic acid inhibits the CYP3A4 enzyme and other metabolic pathways, which is the primary cause of many of its interactions [1.6.1, 1.4.1].

  • Always Inform Your Doctor: Always disclose all medications, including over-the-counter drugs and supplements, to your healthcare provider to prevent dangerous interactions [1.7.3].

In This Article

Fusidic acid is an antibiotic primarily used to treat infections caused by staphylococcal bacteria [1.2.3]. It is available in several forms, including topical creams and ointments, eye drops, and systemic formulations like oral tablets or injections [1.7.1]. While the topical forms are generally considered to have minimal interactions, systemic fusidic acid can interact dangerously with several other medications [1.4.3, 1.8.2]. Understanding these interactions is crucial for preventing severe adverse effects. This article details the medications and drug classes you should not mix with fusidic acid, with a primary focus on the contraindications for its systemic use.

The Critical Interaction: Why You Must Not Mix Systemic Fusidic Acid with Statins

The most significant and life-threatening drug interaction with systemic fusidic acid is with statins, a class of cholesterol-lowering medications [1.3.3]. Concomitant use is strictly contraindicated by many health authorities because it can lead to rhabdomyolysis, a severe condition involving the breakdown of muscle tissue that releases a damaging protein into the bloodstream [1.2.5, 1.3.2]. This can result in kidney failure, permanent disability, and can even be fatal [1.2.5, 1.4.1].

What is Rhabdomyolysis? Rhabdomyolysis occurs when skeletal muscle is rapidly destroyed. As muscle cells disintegrate, they release their contents, including a protein called myoglobin, into the circulation. The kidneys are not equipped to filter large amounts of myoglobin, which can lead to acute kidney injury and failure [1.4.4].

Symptoms of Rhabdomyolysis to Watch For:

  • Severe muscle pain, tenderness, or weakness
  • Dark, reddish-brown, or tea-colored urine
  • General feeling of illness or fatigue
  • Nausea
  • Reduced urine output [1.3.3, 1.4.5]

If you are taking fusidic acid and experience any of these symptoms, you must seek immediate medical attention.

Mechanism of the Interaction The interaction mechanism is complex and not fully understood. Initially, it was thought to be solely because fusidic acid inhibits the CYP3A4 enzyme, which is responsible for metabolizing many statins (like atorvastatin and simvastatin) [1.6.1, 1.4.4]. Inhibiting this enzyme leads to significantly increased levels of the statin in the blood, raising the risk of toxicity [1.4.4]. However, cases of rhabdomyolysis have also been reported with statins that are not primarily metabolized by CYP3A4 (like pravastatin and rosuvastatin) [1.4.1]. This suggests other mechanisms are at play, such as fusidic acid inhibiting transport proteins (like OATP1B1) that help clear statins from the body [1.4.1].

Healthcare guidelines are clear: if treatment with systemic fusidic acid is essential, statin therapy must be temporarily stopped for the duration of the antibiotic treatment and for at least 7 days after the last dose of fusidic acid [1.4.3].

Other Significant Drug Interactions with Systemic Fusidic Acid

While the statin interaction is the most critical, systemic fusidic acid can also interact with other medications, primarily by affecting their metabolism.

Anticoagulants (Blood Thinners) When taken with oral anticoagulants like warfarin or other coumarin derivatives, fusidic acid may enhance their blood-thinning effect, increasing the risk of bleeding [1.5.1]. The mechanism is not fully known but is suspected to involve mutual inhibition of metabolism [1.5.1]. Patients on this combination require close monitoring of their coagulation status (e.g., INR levels), and the anticoagulant dose may need adjustment [1.2.6].

HIV Protease Inhibitors Co-administration with HIV protease inhibitors such as ritonavir and saquinavir is generally not recommended [1.7.3]. This combination can lead to increased plasma concentrations of both fusidic acid and the antiviral drug, potentially causing hepatotoxicity (liver damage) [1.2.6].

Other Antibiotics Fusidic acid can have an antagonistic effect with some other antibiotics. For example, it should not be used with quinolone antibiotics [1.3.2]. Its interaction with penicillins is also complex; to avoid a diminished therapeutic effect, it's sometimes recommended that penicillin be administered two hours before fusidic acid [1.2.3].

Comparison Table: Fusidic Acid Interacting Drugs

Drug Class / Medication Examples Potential Effect of Interaction Recommendation
Statins Atorvastatin, Simvastatin, Pravastatin, Rosuvastatin [1.3.1, 1.3.5] Increased risk of severe and potentially fatal rhabdomyolysis (muscle breakdown) [1.2.5]. Contraindicated. Statin therapy should be stopped during and for 7 days after systemic fusidic acid treatment [1.4.3].
Oral Anticoagulants Warfarin, Acenocoumarol [1.2.2, 1.5.1] Increased anticoagulant effect, leading to a higher risk of bleeding [1.5.1]. Use with caution. Requires close monitoring and potential dose adjustment of the anticoagulant [1.2.6].
HIV Protease Inhibitors Ritonavir, Saquinavir [1.2.1] Increased concentrations of both drugs, leading to a risk of hepatotoxicity (liver toxicity) [1.2.6]. Avoid co-administration if possible [1.7.3].
Quinolone Antibiotics Ciprofloxacin [1.7.1] Antagonistic effect, potentially reducing the efficacy of both antibiotics [1.3.2]. Avoid combination.
Cyclosporin (Immunosuppressant) May lead to an increased concentration of cyclosporin [1.2.6]. Use with caution and monitor drug levels.

Topical Fusidic Acid vs. Systemic Use: Do Interactions Differ?

The risk of significant drug interactions is almost exclusively associated with systemic fusidic acid (tablets and injections) [1.4.3]. This is because it is absorbed into the bloodstream, where it can interfere with the metabolism of other drugs throughout the body.

Topical fusidic acid (creams, ointments, and eye drops) has very low systemic absorption. Therefore, clinically significant drug interactions are considered highly unlikely [1.8.2, 1.8.5]. The UK's NHS states there are no known medicines that cause problems when taken with fusidic acid cream, ointment, or eye drops [1.8.2]. However, as a general precaution, it is always best to inform your doctor about all medications you are using, including over-the-counter products and supplements [1.7.3].

Conclusion

Knowing what not to mix with fusidic acid is a critical component of medication safety. The absolute contraindication is the combination of systemic fusidic acid and any statin, due to the high risk of life-threatening rhabdomyolysis [1.2.5]. Significant caution is also necessary when combining it with oral anticoagulants and HIV protease inhibitors due to risks of bleeding and liver toxicity, respectively [1.2.6]. While topical fusidic acid is considered safe from these interactions, the importance of open communication with your healthcare provider cannot be overstated. Always provide a complete list of your current medications to your doctor and pharmacist to ensure they can screen for any potential interactions and keep you safe.


Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before starting, stopping, or changing any medication.

Authoritative Link: Systemic fusidic acid and interaction with statins - GOV.UK

Frequently Asked Questions

Yes, it is generally considered safe. The serious interactions, like the one with statins, are associated with systemic (oral or injected) fusidic acid. Topical fusidic acid has minimal absorption into the bloodstream, making significant drug interactions highly unlikely [1.8.2, 1.4.3].

The main symptoms are those of rhabdomyolysis, which include unexplained muscle pain, tenderness, or weakness, and dark, red, or tea-colored urine. If you experience these, seek medical help immediately [1.3.3].

You should stop taking the statin for the entire duration of the fusidic acid treatment. It is recommended to reintroduce the statin no earlier than 7 days after the last dose of systemic fusidic acid to ensure it has been cleared from your system [1.4.3].

Yes, systemic fusidic acid can increase the effect of oral anticoagulants like warfarin, leading to an increased risk of bleeding. If this combination is necessary, your doctor will need to monitor you closely and may need to adjust your warfarin dose [1.2.6, 1.5.1].

The combination is dangerous because fusidic acid inhibits the body's ability to metabolize and clear the statin. This leads to very high levels of the statin in the blood, which can become toxic to muscle tissue and cause rapid, severe muscle breakdown (rhabdomyolysis) that can be fatal [1.4.1, 1.4.4].

Fusidic acid may have an antagonistic (opposing) effect when combined with quinolone antibiotics like ciprofloxacin [1.3.2, 1.7.1]. You should always inform your doctor of all medications you are taking.

The patient information leaflet for oral fusidic acid advises avoiding alcohol. It is always best to discuss the use of alcohol with your healthcare professional when taking any medication [1.3.5].

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.